[1]罗　凤,陈永顺,李　雪,等.食管癌患者抑郁状态与血清瘦素、胃促生长素水平相关性分析[J].新乡医学院学报,2019,36(3):258-261.[doi:10.7683/xxyxyxb.2019.03.013]
　LUO Feng,CHEN Yong-shun,LI Xue,et al.Correlation between the depression and serum leptin,ghrelin levels in patients with esophageal cancer[J].Journal of Xinxiang Medical University,2019,36(3):258-261.[doi:10.7683/xxyxyxb.2019.03.013]
点击复制

食管癌患者抑郁状态与血清瘦素、胃促生长素水平相关性分析
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
36
期数:
2019年3
页码:
258-261
栏目:
临床研究
出版日期:
2019-03-05

文章信息/Info

Title:
Correlation between the depression and serum leptin,ghrelin levels in patients with esophageal cancer
作者:
罗　凤1; 陈永顺2; 李　雪1; 方　方1; 刘　辉1; 王旭颖1
（1.河南省肿瘤医院放疗科　郑州大学附属肿瘤医院放疗科，河南　郑州　450008；2.武汉大学人民医院放疗科，湖北　武汉　430060）
Author(s):
LUO Feng1; CHEN Yong-shun2; LI Xue1; FANG Fang1; LIU Hui1; WANG Xu-ying1
(1.Department of Radiation Oncology,Henan Cancer Hospital;the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008,Henan Province,China;2.Department of Radiation Oncology,the Renmin Hospital of Wuhan University,Wuhan 430060,Hubei Province,China)
关键词:
食管癌; 放射治疗; 抑郁; 瘦素; 胃促生长素
Keywords:
esophageal carcinoma; radiotherapy; depression; leptin; ghrelin
DOI:
10.7683/xxyxyxb.2019.03.013
文献标志码:
A
摘要:
目的　探讨食管癌患者抑郁状态与血清瘦素、胃促生长素水平的关系。方法　选择河南省肿瘤医院放疗科2016年2月至2017年3月收治的45例成年男性食管癌患者为研究对象，根据是否合并抑郁症分为抑郁症组（n=20）和非抑郁症组（n=25）；食管癌患者均接受放射治疗，合并抑郁症患者同时进行抗抑郁治疗。另选择20例健康成年男性作为对照组。检测所有受试者血清瘦素、胃促生长素水平,治疗前后采用汉密尔顿抑郁量表（HAMD）评估食管癌患者精神状态。比较2组受试者体质量、体质量指数（BMI）及激素水平等,并分析食管癌患者抑郁状态与血清瘦素和胃促生长素水平的相关性。结果　非抑郁症组和抑郁症组患者治疗前后体质量、BMI均显著低于对照组（P<0.05），抑郁症组与非抑郁症组患者治疗前体质量、BMI比较差异均无统计学意义（P>0.05）。抑郁症组与非抑郁症组患者治疗后体质量、BMI显著低于治疗前（P<0.05）；治疗后，抑郁症组患者的体质量、BMI显著低于非抑郁症组（P<0.05）。非抑郁症组患者治疗前血清瘦素水平与对照组比较差异无统计学意义（P>0.05），治疗后血清瘦素水平显著低于对照组（P<0.05）；抑郁症组患者治疗前和治疗后血清瘦素水平均显著低于对照组（P<0.05）。非抑郁症组患者治疗后血清瘦素水平显著低于治疗前（P<0.05），抑郁症组患者治疗后血清瘦素水平与治疗前比较差异无统计学意义（P>0.05）。治疗前，抑郁症组与血清瘦素水平显著低于非抑郁症组（P<0.05）；治疗后，抑郁症组与非抑郁症组患者血清瘦素水平比较差异无统计学意义（P>0.05）。3组患者血清胃促生长素水平比较差异均无统计学意义（P>0.05）。食管癌患者精神状态与血清胃促生长素水平呈正相关（r=0.360，P<0.05），与血清瘦素水平呈负相关（r=-0.412，P<0.05）。结论　食管癌患者的抑郁状态与血清瘦素水平呈负相关，与胃促生长素水平呈正相关。
Abstract:
Objective　To study the correlation between the depression and serum leptin,ghrelin levels in patients with esophageal cancer (EC).Methods　Forty-five male adult patients with EC in the Department of Radiation Oncology,Henan Cancer Hospital from February 2016 to March 2017 were chosen as study objects,the EC patients were divided into depression group（n=20）and non-depression group（n=25）according to whether they had depression or not.All EC patients received radiotherapy,while the patients with depression received antidepressant therapy.Twenty male healthy adult were recruited as control group.The levels of leptin,ghrelin in serum of all subjects were detected.Depression status was evaluated by hamilton depression scale (HAMD) before and after treatment.The body weight,body mass index(BMI) and hormone levels were compared between the two groups.The correlation between depression status and serum levels of leptin,gastrin were analyzed.Results　The body weight,BMI of patients in depression group and non-depression group were significantly lower than those in the control group before and after treatment (P<0.05).There was no significant difference in the body weight,BMI of patients in depression group and non-depression group before treatment(P>0.05).The weight,BMI of patients in depression group and non-depression group after treatment were significantly lower than those before treatment (P<0.05).After treatment,the body weight,BMI of patients in depression group were significantly lower than those in non-depression group (P<0.05).There was no significant difference in the serum level of leptin between non-depression group and control group before treatment (P>0.05),but the serum level of leptin of patients in non-depressive group was significantly lower than that in the control group after treatment (P<0.05).The serum level of leptin of patients in depression group was significantly lower than that in the control group before and after treatment (P<0.05).The serum level of leptin of patients in non-depression group after treatment was significantly lower than that before treatment (P<0.05);there was no significant difference in the serum level of leptin of patients in depression group between after treatment and before treatment (P>0.05).Before treatment,the serum level of leptin of patients in depression group was significantly lower than that in non-depression group(P<0.05);after treatment,there was no significant difference in the serum level of leptin between depression group and non-depression group(P>0.05).There was no significant difference in the level of serum ghrelin among the three groups (P>0.05).The mental status of EC patients was positively correlated with the serum level of ghrelin(r=0.360,P<0.05) and was negatively correlated with the serum level of leptin (r=-0.412,P<0.05).Conclusion　Depression can change the serum levels of leptin and ghrelin in patients with EC,and appropriate antipsychotic treatment may improve the prognosis of patients by changing their body mass.

参考文献/References:

［1］　SIEGEL R L,MILLER K D,JEMAL A.Cancer Statistics,2017［J］.CA Cancer J Clin,2015,60(5):277-300.
［2］　刘秀芳,王超博,张海,等.养阴法对中晚期食管癌患者放化疗后生命质量及免疫功能的影响研究［J］.世界中医药,2018,13(8):1921-1924.
［3］　VAN CUTSEM E,ARENDS J.The causes and consequences of cancer-associated malnutrition［J］.Eur J Oncol Nurs,2005，9 （Suppl 2）:S51-S63.
［4］　CAO Y,CHEN X,XIE H,et al.Correlation between electroencep-halogram alterations and frontal cognitive impairment in esophageal cancer patients complicated with depression［J］.Chin Med J (Engl),2017,130(15):1785-1790.
［5］　HELLSTADIUS Y,LAGERGREN J,ZYLSTRA J,et al.A longitudinal assessment of psychological distress after oesophageal cancer surgery［J］.Acta Oncol，2017，56(5):746-752.
［6］　李予春,李强,冯砚国,等.认知行为疗法联合米氮平治疗脑卒中后抑郁疗效观察［J］.新乡医学院学报,2018,35(9):816-819.
［7］　ZEMAN M,JIRAK R,JACHYMOVA M,et al.Leptin,adiponectin,leptin to adiponectin ratio and insulin resistance in depressive women［J］.Neuro Endocrinol Lett,2009,30(3):387-395.
［8］　KERENIDI T,LADA M,TSAROUCHA A,et al.Clinical significance of serum adipokines levels in lung cancer［J］.Med Oncol,2013,30(2):507.
［9］　WOLF I,SADETZKI S,KANETY H,et al.Adiponectin,ghrelin,and leptin in cancer cachexia in breast and colon cancer patients［J］.Cancer,2006,106(4):966-673.
［10］　GARCIA J M,GARCIA-TOUZA M,HIJAZI R A,et al.Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia［J］.J Clin Endocrinol Metab,2005,90(5):2920-2926.
［11］　JUNG K H,JO K H,JINA Y,et al.Pathophysiological role of hormones and cytokines in cancer cachexia［J］.J Korean Med Sci,2012,27(2):128-134.
［12］　ASHITANI J,MATSUMOTO N,NAKAZATO M.Ghrelin and its therapeutic potential for cachectic patients［J］.Peptides,2009,30(10):1951-1956.
［13］　GUNEY Y,OZEL TURKCU U,HICSONMEZ A,et al.Ghrelin may reduce radiation-induced mucositis and anorexia in head-neck cancer［J］.Med Hypotheses,2007,68(3):538-540.
［14］　BOLUKBAS F F,KILIC H,BOLUKBAS C,et al.Serum leptin concentration and advanced gastrointestinal cancers:a case controlled study［J］.BMC Cancer,2004,4(1):29-30.
［15］　AKINCI M,KOSOVA F,CETIN B,et al.Leptin levels in thyroid cancer［J］.Asian J Surg,2009,32(4):216-223.
［16］　MACCIòA,MADEDDU C,GRAMIGNANO G,et al.Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer:preliminary results and therapeutic implications［J］.J Mol Med (Berl),2010,88(7):677-686.
［17］　KOWALCZUK A,WIECEK A,FRANEK E,et al.Plasma concentration of leptin,neuropeptide Y and tumor necrosis factor alpha in patients with cancers,before and after radio- and chemotherapy［J］.Pol Arch Med Wewn,2001,106(2):657-668.
［18］　王剑锋,方芳,于雷.营养干预对头颈部肿瘤急性放射性口腔粘膜反应的影响［J］.肠外与肠内营养杂志,2018,25(1):28-31.
［19］　WALLACE A M,KELLY A,SATTAR N,et al.Circulating concentrations of "free" leptin in relation to fat mass and appetite in gastrointestinal cancer patients［J］.Nutr Cancer,2002,44(2):157-160.
［20］　HRYHORCZUK C,SHARMA S,FULTON S E.Metabolic disturbances connecting obesity and depression［J］.Front Neurosci,2013,7:177.

相似文献/References:

[1]王桂荣,王一川,付怀平,等.532例子宫颈癌放射治疗疗效观察[J].新乡医学院学报,1988,5(01):042.
[2]原志庆,王凤荣,吴国祥,等.食管癌切除标本断端残留癌的流式细胞分析[J].新乡医学院学报,1991,8(01):012.
[3]彭明轩,张一峰.食管癌与贲门癌238例手术治疗及其并发症分析[J].新乡医学院学报,1992,9(01):048.
[4]刘玉梅,申维玺,姚卫华,等.氟尿嘧啶合并醛氢叶酸治疗食管癌疗效评价[J].新乡医学院学报,1995,12(02):123.
[5]原志庆,许春雷.瘤体内DNA倍体异质性与食管鳞状细胞癌病理特性的关系[J].新乡医学院学报,1995,12(01):005.
[6]常银江,马森林,王守义,等.上段食管癌切除后食管床内胃食管颈部吻合术[J].新乡医学院学报,1996,13(02):143.
[7]王俊英,李国群,董长宪,等.食管癌合并糖尿病患者的围手术期处理[J].新乡医学院学报,1996,13(02):151.
[8]陈国荣.中晚期食管癌夹心治疗近期疗效分析 [J].新乡医学院学报,1997,14(02):150.
[9]李慧清,李汉臣,杨红伟,等.不同食管胃吻合方法术后生活质量分析[J].新乡医学院学报,1997,14(03):213.
[10]郭玉军,吴阶清,刘新秋,等.双介入疗法治疗晚期食管癌[J].新乡医学院学报,1997,14(03):287.

更新日期/Last Update: 2019-03-05